Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma.
about
Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis.Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysisPrognostic Significance of Neutrophil-to-Lymphocyte Ratio in Colorectal Liver Metastasis: A Systematic Review and Meta-AnalysisImmunotherapeutic Approaches to Biliary Cancer.A long-term survivor of hilar cholangiocarcinoma with resection of recurrent peritoneal dissemination after R0 surgery: a case report.Activation of Fas/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells.The correlation of neutrophil-to-lymphocyte ratio with the presence and activity of myasthenia gravis.Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages.Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody.Prognostic Implication of Inflammation-based Prognostic Scores in Patients with Intrahepatic Cholangiocarcinoma Treated with First-line Gemcitabine plus Cisplatin.The Prognostic Impact of Controlling Nutritional Status (CONUT) in Intrahepatic Cholangiocarcinoma Following Curative Hepatectomy: A Retrospective Single Institution Study.A Novel Biomarker-Based Preoperative Prognostic Grading System for Predicting Survival After Surgery for Intrahepatic Cholangiocarcinoma.Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis.Current landscape and future directions of biomarkers for predicting responses to immune checkpoint inhibitors
P2860
Q33762053-07BCD026-6932-4DEB-99D2-673F9FA7030DQ33829684-8D582460-699E-4F68-BD04-E7A24988E74EQ36079922-B5A780E5-1624-485D-B165-C102EE9E25D8Q38703148-51BDCE7D-C468-48AA-ACB9-A1C6DD1AC940Q42692482-CE267CD0-C44D-4209-9307-2F7723C4706EQ43185882-D9075C77-AC78-4BC5-859A-6185F8095C23Q44166500-44E7475B-C7F4-4171-81DB-977AA6E6EA3DQ47141807-E67E87DB-6F73-4D5D-A8D0-0A994305001CQ47331134-EBE32DCA-F1EC-4817-A8D3-E9532B708BF6Q47388061-F46E821C-35F7-46F5-A344-ABC3CBB4E2E7Q50193510-FF6793B3-3446-49F2-AF84-33F556096E93Q50941885-B9EEFDC6-8298-4FA5-8301-3C982A0F0639Q55492890-2660578E-5CD4-408D-9A27-786C1EE832FAQ56890243-41C002CB-FA03-4C66-9612-5777943AD80C
P2860
Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Elevated neutrophil-to-lymphoc ...... trahepatic cholangiocarcinoma.
@en
Elevated neutrophil-to-lymphoc ...... trahepatic cholangiocarcinoma.
@nl
type
label
Elevated neutrophil-to-lymphoc ...... trahepatic cholangiocarcinoma.
@en
Elevated neutrophil-to-lymphoc ...... trahepatic cholangiocarcinoma.
@nl
prefLabel
Elevated neutrophil-to-lymphoc ...... trahepatic cholangiocarcinoma.
@en
Elevated neutrophil-to-lymphoc ...... trahepatic cholangiocarcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Elevated neutrophil-to-lymphoc ...... trahepatic cholangiocarcinoma.
@en
P2093
Jianlin Chen
Shengping Li
Shuhong Li
Yongcheng Liu
Zeyu Shuang
P2860
P304
50963-50971
P356
10.18632/ONCOTARGET.7680
P407
P577
2016-02-24T00:00:00Z